| Primary |
| Depression |
22.8% |
| Ill-defined Disorder |
13.9% |
| Anxiety |
8.9% |
| Cervicogenic Headache |
5.1% |
| Sleep Disorder |
5.1% |
| Smoking Cessation Therapy |
5.1% |
| Arthralgia |
3.8% |
| Drug Use For Unknown Indication |
3.8% |
| Nervousness |
3.8% |
| Pain |
3.8% |
| Anaphylactic Reaction |
2.5% |
| Blood Triglycerides Increased |
2.5% |
| Chronic Fatigue Syndrome |
2.5% |
| Cystitis Interstitial |
2.5% |
| Goitre |
2.5% |
| Hypothyroidism |
2.5% |
| Migraine |
2.5% |
| Pain In Extremity |
2.5% |
| Pruritus |
2.5% |
| Bladder Pain |
1.3% |
|
| Somnolence |
17.6% |
| Gynaecomastia |
7.8% |
| Vision Blurred |
7.8% |
| Weight Increased |
7.8% |
| Death |
5.9% |
| Dermatitis Allergic |
3.9% |
| Hypertension |
3.9% |
| Nausea |
3.9% |
| No Adverse Event |
3.9% |
| Overdose |
3.9% |
| Spinal Column Injury |
3.9% |
| Suicide Attempt |
3.9% |
| Testicular Pain |
3.9% |
| Therapeutic Response Unexpected With Drug Substitution |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Urticaria |
3.9% |
| Vomiting |
3.9% |
| Anosmia |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Blood Prolactin Increased |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
25.9% |
| Depression |
7.9% |
| Attention Deficit/hyperactivity Disorder |
6.3% |
| Bipolar I Disorder |
6.3% |
| Anxiety |
4.8% |
| Anaphylactic Reaction |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Agitation |
1.6% |
| Chronic Fatigue Syndrome |
1.1% |
| Hallucination, Olfactory |
1.1% |
| Migraine |
1.1% |
| Panic Attack |
1.1% |
| Panic Disorder |
1.1% |
| Schizophrenia, Paranoid Type |
1.1% |
| Sleep Disorder |
1.1% |
| Bladder Pain |
0.5% |
| Cervicogenic Headache |
0.5% |
| Gammopathy |
0.5% |
| Goitre |
0.5% |
|
| Weight Increased |
24.3% |
| Tremor |
10.8% |
| Somnolence |
8.1% |
| Drug Hypersensitivity |
5.4% |
| Open Angle Glaucoma |
5.4% |
| Overdose |
5.4% |
| Toxic Epidermal Necrolysis |
5.4% |
| Blood Prolactin Increased |
2.7% |
| Cardiac Disorder |
2.7% |
| Dyspnoea |
2.7% |
| Heart Valve Insufficiency |
2.7% |
| Intraocular Pressure Increased |
2.7% |
| Loss Of Consciousness |
2.7% |
| Malabsorption |
2.7% |
| Medication Error |
2.7% |
| No Adverse Event |
2.7% |
| Photophobia |
2.7% |
| Rash |
2.7% |
| Rhabdomyolysis |
2.7% |
| Sedation |
2.7% |
|
| Concomitant |
| Depression |
19.6% |
| Product Used For Unknown Indication |
19.6% |
| Pain |
5.7% |
| Breast Cancer Metastatic |
5.5% |
| Anxiety |
5.4% |
| Drug Use For Unknown Indication |
4.8% |
| Bipolar Disorder |
4.5% |
| Sleep Disorder |
4.5% |
| Multiple Myeloma |
4.1% |
| Hypertension |
3.7% |
| Insomnia |
3.5% |
| Diabetes Mellitus |
3.2% |
| Irritable Bowel Syndrome |
2.8% |
| Breast Cancer |
2.2% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Contraception |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Arthritis |
1.7% |
| Metastases To Bone |
1.7% |
|
| Weight Increased |
13.5% |
| Type 2 Diabetes Mellitus |
11.1% |
| Vomiting |
9.5% |
| White Blood Cell Count Decreased |
9.5% |
| Vulvovaginal Candidiasis |
5.6% |
| Suicidal Ideation |
4.8% |
| Metabolic Disorder |
4.0% |
| Nausea |
4.0% |
| Pancreatitis |
4.0% |
| Weight Decreased |
4.0% |
| Constipation |
3.2% |
| Drug Ineffective |
3.2% |
| Insomnia |
3.2% |
| Neutropenia |
3.2% |
| Pneumonia |
3.2% |
| Somnolence |
3.2% |
| Thinking Abnormal |
3.2% |
| Uterine Cancer |
3.2% |
| Breast Cancer Female |
2.4% |
| Depression |
2.4% |
|
